However, the combination treatment with MAC-3-190 and anti-PD-1 did not exhibit a significant impact on mouse survival, despite the potent tumor growth inhibition observed at day 18 (Supplementary Figure S8). This evidence concerns the gene PDCD1 and neoplasm.